Estrogen clinical trials

Explore recruiting estrogen clinical trials.

Recruiting estrogen studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Estrogen trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Is there an effect of local vaginal estrogen treatment on the hemostatic parameters in postmenopausal women?

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Use of Imatinib to convert triple negative breast cancer into ER-positive breast cancer: I-CONIC

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

Use of a new diagnostic tool in the detection and characterization of endometriosis lesions. ENDO-TEP

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Endocrine, Cardiovascular, Pharmacological, and Physiological Aspects of Sex Hormone Therapy in Turner Syndrome - Study 2

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

JAKIH « A phase 2 open-label single-arm trial of JAK1 inhibitor for the treatment of large inflammatory hepatocellular adenomas »

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 1b/2 Open-Label Study of Samuraciclib in Combination with Elacestrant in Participants with Metastatic or Locally Advanced Hormone-Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer

France, Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Estrogen trials by city

Estrogen in Toronto Estrogen in Vancouver Estrogen in Montreal Estrogen in Calgary Estrogen in Edmonton Estrogen in Ottawa Estrogen in Winnipeg Estrogen in Quebec City Estrogen in Hamilton Estrogen in Kitchener Estrogen in London Estrogen in Halifax Estrogen in New York Estrogen in Los Angeles Estrogen in Chicago Estrogen in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease